8 completed. 8 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 8 |
| Phase 1 | 2 | Completed 2 |
Follow Biotest: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection Cytotect - Kidney Transplantation, CMV Infection | Phase 2 | Completed | University Hospital, Bordeaux | 42 | 2021-11-17 | 2026-05-12 |
| Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 Trimodulin, Placebo (human albumin 1%) - Covid19 | Phase 2 | Completed | Biotest | 166 | 2020-10-06 | 2023-01-10 |
| Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus BT063, Placebo - Systemic Lupus Erythematosus | Phase 2 | Completed | Biotest | 36 | 2015-09-28 | 2020-01-27 |
| BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma BT062 , intravenous administration - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Biotest Pharmaceuticals Corporation | 64 | 2012-07-03 | 2019-07-23 |
| Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP BT086, 1% Human Albumin infusion - Community Acquired Pneumonia | Phase 2 | Completed | Biotest | 160 | 2011-08-01 | 2015-07-29 |
| Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX) BT061, Placebo - Rheumatoid Arthritis | Phase 2 | Completed | Biotest | 127 | 2010-12-01 | 2015-02-20 |
| Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma BT062 - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Biotest Pharmaceuticals Corporation | 35 | 2010-08-01 | 2019-07-30 |
| Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis BT061, placebo treatment - Psoriasis Vulgaris | Phase 2 | Completed | Biotest | 49 | 2010-02-01 | 2012-03-13 |
Community-Acquired Pneumonia (2) · Multiple Myeloma (2) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · COVID-19 (1) · Cytomegalovirus Infections (1) · Lupus Erythematosus, Systemic (1) · Pneumonia, Bacterial (1) · Recurrence (1) · Respiratory Distress Syndrome (1)
indatuximab ravtansine (2) · Administration, Intravenous (1) · cytomegalovirus-specific hyperimmune globulin (1) · trimodulin (1)
Spain (3) · Czechia (2) · France (2) · Germany (2) · Hungary (2) · Poland (2) · United States (2) · Belarus (1) · Belgium (1) · Brazil (1) · Georgia (1) · Italy (1) · Latvia (1) · Russia (1) · Serbia (1)
Antoni Torres, MD (1) · Kenneth C Anderson, MD (1) · Kenneth C. Anderson, MD (1) · Nemanja Damjanov, Professor (1) · Tobias Welte, MD (1)
PMID 29632995, PMID 33351126, PMID 33687069, PMID 34529955, PMID 39138518